Dr Sulaiman Al Habib Medical Services (4013) Q2 2026 earnings summary

Executive summary

• Revenue for the six months ended 30 June 2026 reached SAR 7.44 billion, up from SAR 6.54 billion year-over-year.

• Net profit for the six-month period was SAR 1.22 billion, compared to SAR 1.18 billion in the prior year.

• Total comprehensive income for the six months was SAR 1.22 billion, up from SAR 1.18 billion year-over-year.

• Interim dividends of SAR 812 million were distributed during the period.

Financial highlights

• Gross profit for the six months was SAR 2.18 billion, compared to SAR 2.09 billion year-over-year.

• Operating profit for the six months reached SAR 1.36 billion, up from SAR 1.27 billion year-over-year.

• Earnings per share for the six months were SAR 3.33, compared to SAR 3.28 in the prior year.

• Cash and cash equivalents at period end were SAR 2.32 billion, up from SAR 2.28 billion at year-end 2025.

• Net cash from operating activities for the six months was SAR 1.83 billion, up from SAR 1.20 billion year-over-year.

Outlook and guidance

• Management is assessing the impact of IFRS 18, which will affect financial statement presentation from 2027 but is not expected to impact profit, EPS, equity, or net cash flows.

• The Group continues to monitor regional geopolitical developments, with no material impact on current results but ongoing assessment for future periods.